Navamedic
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Navamedic ASA is a Nordic pharma company with a footprint in Northern Europe. We are a reliable supplier of high-quality products, delivered to hospitals and through pharmacies, meeting the specific medical needs of patients and consumers. Our product portfolio consists of prescription and OTC pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. Navamedic is present in all Nordic countries, the Baltics and Benelux and has sales of specific products even in other European countries like UK and Greece. Our headquarter is in Oslo, Norway and we are listed on the Oslo Stock Exchange (ticker: NAVA).
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-11 13:03 |
Earnings Release
Navamedic ASA: Invitation to 2025 2nd quarter presentation
|
English | 2.0 KB | |
| 2025-07-15 12:32 |
Regulatory News Service
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
|
English | 5.7 KB | |
| 2025-07-15 08:25 |
Share Issue/Capital Change
Navamedic ASA: Ex. subscription rights today
|
English | 523 bytes | |
| 2025-07-14 15:27 |
Declaration of Voting Results & Voting Rights Announcements
Navamedic ASA - Minutes of Extraordinary General Meeting - Attachment: Navamedi…
|
Norwegian | 354.3 KB | |
| 2025-07-14 15:27 |
Declaration of Voting Results & Voting Rights Announcements
Navamedic ASA - Minutes of Extraordinary General Meeting
|
English | 1.0 KB | |
| 2025-07-11 14:16 |
Director's Dealing
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_JD…
|
Norwegian | 79.4 KB | |
| 2025-07-11 14:16 |
Director's Dealing
Navamedic ASA: Mandatory notice of trade
|
English | 862 bytes | |
| 2025-07-10 10:49 |
Share Issue/Capital Change
Navamedic ASA: Updated key information relating to the rights issue
|
English | 10.0 KB | |
| 2025-06-29 13:36 |
Share Issue/Capital Change
Navamedic ASA - Additional underwriting commitments in the Rights Issue
|
English | 8.8 KB | |
| 2025-06-27 14:14 |
Regulatory News Service
Navamedic ASA: First approval of the medical device OraFID® as primary package …
|
English | 2.8 KB | |
| 2025-06-24 08:00 |
Investor Presentation
Navamedic ASA - Investor presentation regarding the acquisition of the business…
|
English | 1.1 MB | |
| 2025-06-24 08:00 |
Regulatory News Service
Navamedic ASA - Investor presentation regarding the acquisition of the business…
|
English | 1.8 KB | |
| 2025-06-23 17:35 |
Director's Dealing
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_Pr…
|
English | 80.7 KB | |
| 2025-06-23 17:35 |
Director's Dealing
Navamedic ASA: Mandatory notice of trade
|
English | 876 bytes | |
| 2025-06-23 12:45 |
Pre-Annual General Meeting Information
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in conne…
|
Norwegian | 1.3 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Vimian Group AB | Sweden | VIMIAN | |
|
Virbac | France | FR000 | |
|
Vistin Pharma | Norway | VISTN | |
|
Vivesto | Sweden | VIVE | |
|
WAKAMOTO PHARMACEUTICAL CO.,LTD. | Japan | 4512 | |
|
Xlife Sciences AG | Switzerland | XLS | |
|
Xspray Pharma | Sweden | XSPRAY | |
|
Y.B Urban Renewal - Residential Development LTD | Israel | CSURE-M | |
|
YUKI GOSEI KOGYO CO.,LTD. | Japan | 4531 | |
|
Zentiva 2 | Slovakia | SKF |